Skip to content

Author

S. Mignozzi

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Ovarian Cancer Survival Across the Introduction of Targeted Treatment: A Nationwide Analysis by Histotype and Stage

Background Bevacizumab was approved for targeted therapy of ovarian cancer in 2011 by the European Medicines Agency, with the subsequent introduction of PARP (poly[ADP]-ribose polymerase) inhibitors in 2014. Improvements in outcomes of cytoreductive surgery occurred in parallel in many regions. Objectives Population...

S. Mignozzi, Victoria Cooley, C. B. Trewin-Nybråten et al. · 0 citations
Open access Sep 2026

Trends in Pancreatic Cancer Mortality in Europe and the USA, 1990-2024, and Predictions to 2030

Introduction Pancreatic cancer is the fourth leading cause of cancer-related mortality in Europe, accounting for approximately 140,000 deaths in 2024. While mortality for many major cancers has declined over recent decades, pancreatic cancer did not decline and is characterized by a poor prognosis and high fatality ra...

Riccardo Zanzi, G. Alicandro, C. la Vecchia et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.